| Name | Title | Contact Details |
|---|
We help you attract an online audience and boost results with content that uniquely matches user intent. Using the deep learning insights of the Searchmetrics Suite and Searchmetrics Content Experience platform, we navigate the shifting priorities of search engines and help you outrank your competition. Search has evolved into a data-driven field that requires powerful software to guide companies through discovery, briefing, optimization and measurement of engaging storytelling. There`s only one platform that owns its data: Searchmetrics, the world`s #1 Search and Content Marketing Platform. We don`t rely on data from third parties and we`ve been studying search and content trends since 2005 − compiling the industry`s largest global and historical database. Searchmetrics uncovers the opportunities and pitfalls of online marketing. Our award-winning Searchmetrics products bring search engine optimization and content creation together for the first time, offering marketers an ultimate platform for creating the moments that shape customers` decisions and brand preferences. We offer competitive insights and hands-on consulting to help our customers create predictable returns in earned media. Our SEO Visibility Score − trusted by reputable media sources such as The New York Times, Bloomberg and The Guardian − reliably gauges your online presence. Searchmetrics reveals the connection between social media links and overall engagement, and its analytics make clear which content performs best. We have over 100,000 users worldwide, including respected brands such as T-Mobile, eBay and Siemens.
uoo1.com is a Arkansas, AR-based company in the Software and Internet sector.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Were the worlds only factory-direct marketplace for bulk raw ingredients used in food, beverages, dietary supplements, vitamins, skin care & animal products.
Epsilon® is an all-encompassing global marketing innovator. We provide unrivaled data intelligence and customer insights, world-class technology including loyalty, email and CRM platforms and data-driven creative, activation and execution. Epsilon’s di...